166 related articles for article (PubMed ID: 1712475)
1. Characterization by image cytometry of duct epithelial proliferative disease of the breast.
King EB; Chew KL; Hom JD; Duarte LA; Mayall B; Miller TR; Neuhaus JM; Wrensch MR; Petrakis NL
Mod Pathol; 1991 May; 4(3):291-6. PubMed ID: 1712475
[TBL] [Abstract][Full Text] [Related]
2. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
[TBL] [Abstract][Full Text] [Related]
3. Nuclear cytometric changes in breast carcinogenesis.
Mommers EC; Poulin N; Sangulin J; Meijer CJ; Baak JP; van Diest PJ
J Pathol; 2001 Jan; 193(1):33-9. PubMed ID: 11169513
[TBL] [Abstract][Full Text] [Related]
4. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
Piubello Q; Montemezzi S; D'Atri C
Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
[TBL] [Abstract][Full Text] [Related]
5. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
[TBL] [Abstract][Full Text] [Related]
6. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
8. [Whole organ giant section histopathologic studies on breast cancer. III. Benign lesions in cancerous breast and near the tumor areas].
Zhang ZD
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):20-2. PubMed ID: 8392928
[TBL] [Abstract][Full Text] [Related]
9. Quantitative study of breast cancer progression: different pathways for various in situ cancers.
Mariuzzi L; Mombello A; Granchelli G; Rucco V; Tarocco E; Frank D; Davis J; Thompson D; Bartels H; Mariuzzi GM; Bartels PH
Mod Pathol; 2002 Jan; 15(1):18-25. PubMed ID: 11796837
[TBL] [Abstract][Full Text] [Related]
10. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
11. Proliferative lesions of the breast lobules. A morphometric analysis.
Maiorana A; Nigrisoli E; Sannicola C; Maiorana MC; Cavallari V
Pathologica; 1990; 82(1079):271-7. PubMed ID: 2091011
[TBL] [Abstract][Full Text] [Related]
12. [The Ljubljana classification of epithelial hyperplastic laryngeal lesions: a morphometric evaluation of nuclear pleomorphism].
Serio G; Gale N; Pennella A; Dalena AM; Giardina C; Valente T; Lettini T; Ricco R; Resta L
Pathologica; 2002 Dec; 94(6):290-8. PubMed ID: 12540992
[TBL] [Abstract][Full Text] [Related]
13. [Pathological characterization of atypical ductal hyperplasia of the breast].
Hoshi K; Tokunaga M; Mochizuki M; Ohtake T; Katagata N; Wakasa H; Suzuki T
Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():36-41. PubMed ID: 7747990
[TBL] [Abstract][Full Text] [Related]
14. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Masood S; Loya A; Khalbuss W
Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
[TBL] [Abstract][Full Text] [Related]
15. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical differentiation of atypical hyperplasia vs. carcinoma in situ of the breast.
Masood S; Sim SJ; Lu L
Cancer Detect Prev; 1992; 16(4):225-35. PubMed ID: 1281040
[TBL] [Abstract][Full Text] [Related]
17. Image cytometric classification of premalignant breast disease in fine needle aspirates.
King EB; Chew KL; Duarte L; Hom JD; Mayall BH; Miller TR; Petrakis NL
Cancer; 1988 Jul; 62(1):114-24. PubMed ID: 3383110
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
[TBL] [Abstract][Full Text] [Related]
19. Hyperplastic lesions of the human breast: scanning electron microscopy and a review of current knowledge.
Halter SA; Holt DH; Page DL
Scan Electron Microsc; 1981; (Pt 3):11-21. PubMed ID: 6276966
[TBL] [Abstract][Full Text] [Related]
20. Computerized scene segmentation for the discrimination of architectural features in ductal proliferative lesions of the breast.
Anderson NH; Hamilton PW; Bartels PH; Thompson D; Montironi R; Sloan JM
J Pathol; 1997 Apr; 181(4):374-80. PubMed ID: 9196433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
